Guangdong Jiaying Pharmaceutical News

Jiaying Pharmaceutical (002198): Bao Jianfeng from refining the fragrance of plum blossoms comes from the bitter cold

May 19 00:00

Jiaying Pharmaceutical (002198) Review: A Good Harvest of Natural Ice Tablets Is Imminent

財達證券Dec 18, 2015 00:00

[Shen Wan Hongyuan] Jiaying Pharmaceutical: the advantage of acquiring Sands is highlighted, and industry adjustment promotes the transformation of the company.

申萬宏源Apr 23, 2015 00:00

Comment on Jiaying Pharmaceutical (002198) Annual report: the advantage of acquiring Sands highlights the industry adjustment and promotes the transformation of the company.

宏源證券Apr 23, 2015 00:00

[Hongyuan Securities] Jiaying Pharmaceutical: warping tail effect gives birth to beautiful China News

宏源證券Aug 22, 2014 00:00

Jiaying Pharmaceutical (002198): Sampicin capsule phase II trial results were good, Huaqingyuan obtained a forest license

天相投顧May 29, 2014 00:00

[Hongyuan Securities] Jiaying Pharmaceutical: get the policy dividend, the price and volume of traditional medicine will rise.

宏源證券May 21, 2014 00:00

Jiaying Pharmaceutical (002198) dynamic follow-up comments: get the policy dividend and increase the price of traditional medicine.

宏源證券May 21, 2014 00:00

【宏源证券】大立科技:红外商业化在即,尽享先发优势

宏源證券May 8, 2014 00:00

Comments on the quarterly report of Jiaying Pharmaceutical (002198): the Hongmei tablet tree base won the forest certificate for the first time at the beginning of the performance

宏源證券Apr 16, 2014 00:00

[Hongyuan Securities] Jiaying Pharmaceutical: The performance got off to a good start, and the Mei Pianshu base received a forest certificate for the first time

宏源證券Apr 15, 2014 00:00

嘉应制药(002198)：联袂暨大孵化抗肿瘤纳米药物

宏源證券Apr 11, 2014 00:00

【宏源证券】嘉应制药13年报点评:联袂暨大孵化抗肿瘤纳米药物

宏源證券Apr 10, 2014 00:00

嘉应制药(002198)2013年报点评：天然冰片种植基地有望再下一城

宏源證券Mar 5, 2014 00:00

【宏源证券】嘉应制药13年报点评:天然冰片种植基地有望再下一城

宏源證券Mar 4, 2014 00:00

嘉应制药(002198)深度研究：发力“中国好冰片” 请点赞

宏源證券Feb 18, 2014 00:00

【天相投资】嘉应制药:高额费用吞噬公司利润

天相投資Apr 20, 2012 00:00

【天相投资】嘉应制药:主要产品恢复增长 投资收益支撑业绩

天相投資Mar 16, 2011 00:00

【天相投资】嘉应制药:主业堪忧,金沙药业投资收益为主要利润来源

天相投資Oct 20, 2010 00:00

【天相投资】嘉应制药:主导产品营业收入同比增长,金沙药业投资收益稳定

天相投資Aug 5, 2010 00:00